These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24927957)

  • 21. The value of lung function assessment and Testin expression detection in clinicopathological features and prognosis of NSCLC patients.
    Zhang Y; Wang G; Zhang Q; Wang Q; Luo J; Ling C
    J Cardiothorac Surg; 2024 Apr; 19(1):223. PubMed ID: 38627776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocyte-to-Monocyte Ratio Might Serve as a Prognostic Marker in Young Patients with Tongue Squamous Cell Carcinoma.
    Kandathil SA; Peter Truta I; Kadletz-Wanke L; Heiduschka G; Stoiber S; Kenner L; Herrmann H; Huskic H; Brkic FF
    J Pers Med; 2024 Jan; 14(2):. PubMed ID: 38392590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors.
    Ancel J; Dormoy V; Raby BN; Dalstein V; Durlach A; Dewolf M; Gilles C; Polette M; Deslée G
    Front Immunol; 2023; 14():1171649. PubMed ID: 37283751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-derived TLT-1 promotes tumor progression by suppressing CD8+ T cells.
    Tyagi T; Jain K; Yarovinsky TO; Chiorazzi M; Du J; Castro C; Griffin J; Korde A; Martin KA; Takyar SS; Flavell RA; Patel AA; Hwa J
    J Exp Med; 2023 Jan; 220(1):. PubMed ID: 36305874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative inflammatory markers for predicting parathyroid carcinoma.
    Ohkuwa K; Sugino K; Katoh R; Nagahama M; Kitagawa W; Matsuzu K; Suzuki A; Tomoda C; Hames K; Akaishi J; Masaki C; Yoshioka K; Ito K
    Endocr Connect; 2022 Jul; 11(7):. PubMed ID: 35700222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune subgroup analysis for non-small cell lung cancer may be a good choice for evaluating therapeutic efficacy and prognosis.
    Tian Y; Wang J; Wen Q; Su G; Sun Y
    Aging (Albany NY); 2021 May; 13(9):12691-12709. PubMed ID: 33973529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors: Systematic review, meta-analysis, and meta-regression.
    Wen S; Chen N; Hu Y; Huang L; Peng J; Yang M; Shen X; Song Y; Xu L
    Cancer Med; 2021 Mar; 10(5):1690-1714. PubMed ID: 33591628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Lung Cancer: A Systematic Review and Meta-Analysis.
    Jin J; Yang L; Liu D; Li WM
    Technol Cancer Res Treat; 2021; 20():1533033820983085. PubMed ID: 33576324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy.
    Zhao K; Wang C; Shi F; Huang Y; Ma L; Li M; Song Y
    BMC Cancer; 2021 Jan; 21(1):66. PubMed ID: 33446134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of preoperative inflammatory markers in non-small cell lung cancer patients: A multicenter retrospective study.
    Takada K; Takamori S; Matsubara T; Haratake N; Akamine T; Kinoshita F; Ono Y; Wakasu S; Tanaka K; Oku Y; Oba T; Osoegawa A; Tagawa T; Takenoyama M; Shimokawa M; Oda Y; Mori M
    PLoS One; 2020; 15(11):e0241580. PubMed ID: 33137158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Significance of the Preoperative Lymphocyte to Monocyte Ratio in Patients with Gallbladder Carcinoma.
    Xu W; Wu X; Wang X; Yu S; Xu G; Xiong J; Zhang J; Sang X; Zheng Y; Liu W
    Cancer Manag Res; 2020; 12():3271-3283. PubMed ID: 32494191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore, TNM stage and lymphocyte-to-monocyte ratio.
    Gao J; Ren Y; Guo H; Mao R; Xie H; Su H; She Y; Deng J; Yang M; Han B; Zhang Y; Li J; Xie D; Chen C
    Ann Transl Med; 2020 Apr; 8(7):470. PubMed ID: 32395514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).
    Mandaliya H; Jones M; Oldmeadow C; Nordman II
    Transl Lung Cancer Res; 2019 Dec; 8(6):886-894. PubMed ID: 32010567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Context Drives Diversification of Monocytes and Neutrophils in Orchestrating the Tumor Microenvironment.
    Jeong J; Suh Y; Jung K
    Front Immunol; 2019; 10():1817. PubMed ID: 31474975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of pretreatment lymphocyte-to-monocyte ratio in advanced epithelial cancers: a meta-analysis.
    Mao Y; Chen D; Duan S; Zhao Y; Wu C; Zhu F; Chen C; Chen Y
    Cancer Cell Int; 2018; 18():201. PubMed ID: 30534002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer.
    Chen Y; Wang W; Zhang X; Yu X; Xi K; Wen Y; Wang G; Feng X; Zhang L
    Cancer Manag Res; 2018; 10():5411-5422. PubMed ID: 30519089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small cell lung cancer patients treated with EGFR TKI.
    Phan TT; Ho TT; Nguyen HT; Nguyen HT; Tran TB; Nguyen ST
    Int J Gen Med; 2018; 11():423-430. PubMed ID: 30510441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion.
    Lim JU; Yeo CD; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Lee SH
    PLoS One; 2018; 13(7):e0200341. PubMed ID: 30005083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy.
    Wang Y; Qu X; Kam NW; Wang K; Shen H; Liu Q; Du J
    BMC Cancer; 2018 Jun; 18(1):692. PubMed ID: 29940884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis.
    Tham T; Olson C; Khaymovich J; Herman SW; Costantino PD
    Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1663-1670. PubMed ID: 29651542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.